The proceedings are now available:

• Entire proceedings - (16,560 KB)
• Table of Contents
• Proceedings by author alphabetically:
  • Mike Apley (a) proceedings: Rational use of bacterial culture/susceptibility data
  • Mike Apley (a) slides
  • Mike Apley (b) proceedings: Update on the Veterinary Antimicrobial Decision Support (VADS) System
  • Mike Apley (b) slides
  • Dawn Boothe proceedings: Special considerations for drug therapy in the patient with liver disease
  • Dawn Boothe slides
  • Scott A. Brown (a) slides: Supply and demand of veterinary pharmacologists
  • Scott A. Brown (b) slides: Challenges in development of sustained release parenteral formulations
  • Cyril Clarke proceedings: Multiple drug resistance
  • Cyril Clarke slides
  • Virginia Fajt (see Apley (b) and Langston (a) slides also): VADS system: creating virtual animals and bacteria
  • Kasra Kasraian slides: Unique aspects of veterinary formulations
  • Cory Langston (a) slides (see Apley (b) and Fajt also): VADS modeling of antibiotic profiles
  • Cory Langston (b) proceedings: Pharmacotherapy of neonates and pregnant animals
  • Cory Langston (b) slides
  • Cory Langston (b) tables
  • Herve Lefebvre proceedings: Pharmacotherapeutic implications of kidney failure
  • Herve Lefebrve slides
  • Marilyn Martinez, Cory Langston, Tomas Martin, and Dale Conner proceedings: Challenges associated with the evaluation of veterinary product bioequivalence
  • Mark Papich: Pharmacotherapy of immunocompromised animals (at the end of thelinked document)
  • Ted Whittem proceedings: Topical/local vs. systemic antimicrobial therapy
  • Ted Whittem slides